SCM
ANAB icon

Sterling Capital Management’s AnaptysBio ANAB Stock Holding History

Sterling Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66K Sell
69
-49
-42% -$2.97K ﹤0.01% 2658
2026
Q1 		$6.54K Buy
118
+2
+2% +$108 ﹤0.01% 2606
2025
Q4 		$5.62K Buy
116
+69
+147% +$2.69K ﹤0.01% 2851
2025
Q3 		$1.44K Sell
47
-3
-6% -$69 ﹤0.01% 3024
2025
Q2 		$1.11K Buy
50
+23
+85% +$481 ﹤0.01% 3047
2025
Q1 		$502 Buy
27
+7
+35% +$117 ﹤0.01% 2955
2024
Q4 		$265 Hold
20
– – ﹤0.01% 3096
2024
Q3 		$670 Buy
+20
New +$683 ﹤0.01% 2732

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Sterling Capital Management's ANAB Position: Q2 2026 in Review

Sterling Capital Management reduced its AnaptysBio (ANAB) stake by 42% in Q2 2026, selling an estimated $2.97K and leaving 69 shares worth $4.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2658.

Sterling Capital Management first reported a position in ANAB in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.54K in Q1 2026. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Sterling Capital Management held 69 shares of AnaptysBio worth $4.66K as of Q2 2026.
  • Sterling Capital Management sold 49 AnaptysBio shares in Q2 2026, an estimated $2.97K.
  • AnaptysBio made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2658 holding.
  • Sterling Capital Management first reported a position in AnaptysBio in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's AnaptysBio position peaked at $6.54K in Q1 2026.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.